menu
    • menu

    Company profile for GEn1E Lifesciences

    NEW Drugs in Dev: 2
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    GEn1E Lifesciences Inc. (“Genie”) is a biotechnology company with a platform for accelerating cures for inflammatory and age-related diseases. GEn1E’s team includes like-minded professionals with deep experience in Business Development and Strategy, Chemistry, Clinical, Formulations, CMC, Toxicology, Regulatory, Bio-Statistics, PK/ADME, Bioanalytical, IP Law and Health Economics. GEn1E has a pipeline of programs with str...
    GEn1E Lifesciences Inc. (“Genie”) is a biotechnology company with a platform for accelerating cures for inflammatory and age-related diseases. GEn1E’s team includes like-minded professionals with deep experience in Business Development and Strategy, Chemistry, Clinical, Formulations, CMC, Toxicology, Regulatory, Bio-Statistics, PK/ADME, Bioanalytical, IP Law and Health Economics. GEn1E has a pipeline of programs with strong preclinical data. The p38 kinase inhibitors represent a platform for the treatment of various inflammatory and age-related diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    GEn1E LifesciencesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    3000 El Camino Real Palo Alto, CA 94306
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.gen1e.com/
    Linkedin
    Linkedin
    https://ph.linkedin.com/company/gen1e-lifesciences
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/GEn1ELifesci

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    GEn1E Publishes Breakthrough Research on Dual Signal Modulators
    GEn1E Publishes Breakthrough Research on Dual Signal Modulators

    14 Oct 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/10/14/2962413/0/en/GEn1E-Lifesciences-Publishes-Breakthrough-Research-Unveiling-Novel-Mechanism-of-Action-of-Dual-Signal-Modulators-for-Anti-inflammatory-and-Endothelial-Stabilizing-Therapies.html

    GLOBENEWSWIRE
    14 Oct 2024
    Share Share
    GEn1E Lifesciences Announces Partnership with BARDA
    GEn1E Lifesciences Announces Partnership with BARDA

    24 Oct 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/gen1e-lifesciences-announces-partnership-with-barda-to-advance-its-ai-powered-endotyping-program-for-ards-patients-to-further-accelerate-its-novel-lead-compound-gen-1124-301965308.html

    PR NEWSWIRE
    24 Oct 2023
    Share Share
    GEn1E Lifesciences Adds NextGen Selective Immunomodulator Target to Portfolio
    GEn1E Lifesciences Adds NextGen Selective Immunomodulator Target to Portfolio

    26 Jul 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/gen1e-lifesciences-adds-nextgen-selective-immunomodulator-target-to-portfolio-broadens-pipeline-301592168.html

    PRNEWSWIRE
    26 Jul 2022
    Share Share
    GEn1E Lifesciences, a Y Combinator-Backed Company, Granted Exclusive License for University of Maryland, Baltimore Drug Portfolio Compound
    GEn1E Lifesciences, a Y Combinator-Backed Company, Granted Exclusive License for University of Maryland, Baltimore Drug Portfolio Compound

    03 Dec 2019

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/gen1e-lifesciences-a-y-combinator-backed-company-granted-exclusive-license-for-university-of-maryland-baltimore-drug-portfolio-compound-300967641.html

    PRNEWSWIRE
    03 Dec 2019
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search